ERBB2 and neoplasm: Flow cytometry analysis revealed significantly higher percentage of Neu-specific CD8 cells in the tumor and tumor-infiltrating lymph nodes in the MMC-aCTLA4+Dox group compared to the corresponding group that did not receive Dox (Fig. 3C).